Baricitinib - Eli Lilly and Company/Incyte Corporation
At a glance
- Drug Originator Incyte Corporation
- Drug Licenced by Cipla; Dr Reddys Laboratories; Eli Lilly and Company; Lupin; Natco Pharma; Sun Pharmaceutical Industries
- Drug Class Acetonitriles; Anti-inflammatories; Antipsoriatics; Antirheumatics; Azetidines; Eye disorder therapies; Pyrazoles; Pyrimidines; Pyrroles; Skin disorder therapies; Small molecules
- Mechanism of Action Janus kinase 1 inhibitors; Janus kinase 2 inhibitors; TYK2 kinase inhibitors
- USA Patent Applicants ELI LILLY AND CO
- USA Patents 19
- NDAs 1
- International Patents 103
- Patent Applications 2,443
Table of Contents
Disclaimer